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Focal atrial tachycardia from the ostium of the
coronary sinus, 1488
Multislice computed tomography versus intracardiac
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veins before radiofrequency catheter ablation
of atrial fibrillation, 343
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patterns in acute coronary syndromes, 1939
Gender and myocardial salvage after reperfusion
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Gender disparities in the diagnosis and treatment
of non–ST-segment elevation acute coronary
syndromes, 832
Health-related quality of life after interventional or
conservative strategy in patients with unstable
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Long-term cost-effectiveness of clopidogrel given
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Outcomes with the paclitaxel-eluting stent in
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Serial analyses of N-terminal pro-B-type natriuretic
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Serum blood urea nitrogen as an independent
marker of subsequent mortality among
patients with acute coronary syndromes and
normal to mildly reduced glomerular filtration
rates, 1782
Year in interventional cardiology, 1117
Acute myocardial infarction
See Myocardial infarction
Adenosine
Quantitative relation between hemodynamic
changes during intravenous adenosine infusion
and the magnitude of coronary hyperemia,
553
Randomized, double-blinded, placebo-controlled
multicenter trial of adenosine as an adjunct to
reperfusion in the treatment of acute
myocardial infarction (AMISTAD-II), 1776
Adenosine monophosphate-activated protein kinase
Adenosine monophosphate-activated protein
kinase disease mimicks hypertrophic
cardiomyopathy and Wolff-Parkinson-
White syndrome, 922
Adenosine stress myocardial perfusion scintigraphy
Prognostic score for prediction of cardiac mortality
risk after adenosine stress myocardial
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Targeted inhibition of ARK1-associated
phosphoinositide 3-kinase activity preserves
-adrenergic receptor signaling and prolongs
survival in heart failure induced by
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African Americans
See also Race
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Trends in implantable cardioverter-defibrillator
racial disparity, 72
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Afterload reduction in chronic aortic regurgitation
(editorial), 1031
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American College of Cardiology and American
Heart Association methodology for the
selection and creation of performance
measures for quantifying the quality of
cardiovascular care, 1147
Alcohol
Alcohol and the cardiovascular system: research
challenges and opportunities, 1916
Aldosterone
Evidence for an increased rate of cardiovascular
events in patients with primary aldosteronism,
1243
Should we consider aldosterone as the primary
screening target for preventing cardiovascular
events? (editorial), 1249
Ambulatory Holter electrocardiography
Spectrum and prognostic significance of
arrhythmias on ambulatory Holter
electrocardiogram in hypertrophic
cardiomyopathy, 697
Amino acids
Increased skeletal muscle amino acid release with
light exercise in deconditioned patients with
heart failure (letter), 158
Amnesia
Amnesia for loss of consciousness in carotid sinus
syndrome—implications for presentation with
falls, 1841
Amplatzer septal occluders
Cardiac perforation after device closure of atrial
septal defects with the Amplatzer Septal
Occluder, 1213
Long-term outcome of transcatheter secundum-type
atrial septal defect closure using Amplatzer
septal occluders, 505
Reversible atrioventricular block and the Amplatzer
device (letter), 1306
Analgesics
Use of anti-inflammatory analgesics in the patient
with cardiovascular disease (editorial), 1302
Andropause
Andropause and intima media thickness (editorial),
1609
Increased carotid atherosclerosis in andropausal
middle-aged men, 1603
Anemia
Angiotensin-converting enzyme inhibitor as a
risk factor for the development of anemia,
and the impact of incident anemia on
mortality in patients with left ventricular
dysfunction, 391
Further aspects of anemia, heart failure, and
erythropoietin (letter), 1549
Aneurysms
Real-time magnetic resonance-guided endovascular
repair of experimental abdominal aortic
aneurysm in swine, 2069
Transcatheter treatment of atrial septal aneurysm
associated with patent foramen ovale for
prevention of recurrent paradoxical embolism
in high-risk patients, 377
Angina pectoris
Advantage of percutaneous coronary intervention
over medical therapy in angina relief and the
placebo effect (letter), 327
Direct intramyocardial plasmid vascular
endothelial growth factor-A165 gene therapy
in patients with stable severe angina
pectoris, 982
Prodromal angina limits infarct size in the setting
of acute anterior myocardial infarction treated
with primary percutaneous intervention
(letter), 1545
Angiography
Angiographic patterns of restenosis after paclitaxel-
eluting stent implantation, 805
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tomography in heart transplant patients:
comparison with conventional angiography
and impact on clinical management, 1827
Improved diagnostic accuracy with 16-row multi-
slice computed tomography coronary
angiography, 128
Late angiographic stent thrombosis (LAST) events
with drug-eluting stents, 2088
Noninvasive assessment of coronary vasodilation
using magnetic resonance angiography, 104
Relationship between angiographic late loss and
target lesion revascularization after coronary
stent implantation, 1191
Angioplasty
See also Balloon angioplasty; Percutaneous
transluminal coronary angioplasty
Definition of failed lysis may have influenced
outcome in the MERLIN trial (letter), 808
Rescue angioplasty—The MERLIN trial (letter),
806
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Angioscopic follow-up study of coronary ruptured
plaques in nonculprit lesions, 652
Angiotensin II
Absence of acute effects of angiotensin II on atrial
electrophysiology in humans (letter), 154
Angiotensin II inhibition and prevention of atrial
fibrillation and stroke (editorial), 720
Angiotensin II receptor blockade reduces new-onset
atrial fibrillation and subsequent stroke
compared to atenolol, 712
Angiotensin receptor blockers
Prevention of atrial fibrillation with angiotensin
converting enzyme inhibitors and angiotensin
receptor blockers: a meta-analysis, 1833
Angiotensin-converting enzyme inhibitors
Angiotensin-converting enzyme inhibitor as a risk
factor for the development of anemia, and the
impact of incident anemia on mortality in
patients with left ventricular dysfunction, 391
Cardiac medical therapy in patients after
undergoing coronary artery bypass graft
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Effect of perindopril on the onset and progression
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Prevention of atrial fibrillation with angiotensin
converting enzyme inhibitors and angiotensin
receptor blockers: a meta-analysis, 1833
Reduced atrial fibrillation incidence by angiotensin-
converting enzyme inhibitors: a possible
contributing mechanism (letter), 1144
Animal models
Prior exercise training improves the outcome of
acute myocardial infarction in the rat, 931
Anterior fat pad
Preservation of the anterior fat pad and incidence
of postoperative atrial fibrillation following
coronary surgery (letter), 1308
Anticoagulants
See also Aspirin
Ximelagatran: oral direct thrombin inhibitor as
anticoagulant therapy in atrial fibrillation, 1
Anti-inflammatory analgesics
Use of anti-inflammatory analgesics in the patient
with cardiovascular disease (editorial), 1302
Antiplatelet therapy
Resistance to antiplatelet resistance: is it justified?,
1757
Stent thrombosis is associated with an impaired
response to antiplatelet therapy, 1748
Variability in platelet responsiveness to clopidogrel
among 544 individuals, 246
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Atherosclerosis of the aorta: risk factor, risk marker,
or innocent bystander? (letter), 1907
Diagnosis of thin fibrous cap atheromas by a self-
contained intravascular magnetic resonance
imaging probe in ex-vivo human aortas and
in-situ coronary arteries, 1961
Does shear stress modulate both plaque progression
and regression in the thoracic aorta?, 846
Aortic annulus
Hemodynamic comparison of bioprostheses for
complete supraannular position in patients
with small aortic annulus, 2054
Aortic regurgitation
Afterload reduction in chronic aortic regurgitation
(editorial), 1031
Long-term survival and functional results after
aortic valve replacement in asymptomatic
patients with chronic severe aortic
regurgitation and left ventricular dysfunction,
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36th Bethesda Conference: Task force 3: valvular
heart disease, 1334
Year in valvular heart disease, 111
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heart disease, 1326
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heart disease, 1334
Year in valvular heart disease, 111
Aortic valve replacement
Clinical development of percutaneous heart valve
technology, 1554
Long-term survival and functional results after
aortic valve replacement in asymptomatic
patients with chronic severe aortic
regurgitation and left ventricular dysfunction,
1025
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Cardiac resynchronization therapy, central sleep
apnea, and Cheyne-Stokes respiration in
chronic heart failure patients (letter), 633
Inhibition of awake sympathetic nerve activity of
heart failure patients with obstructive sleep
apnea by nocturnal continuous positive airway
pressure, Usui
Treating sleep apnea in heart failure patients:
promises but still no prizes (editorial), 2012
Apolipoprotein CI
Apolipoprotein CI content of triglyceride-rich
lipoproteins independently predicts early
atherosclerosis in healthy middle-aged men,
1013
Apoptosis
Hibernating myocardium, apoptosis, and a simple
mathematical task (letter), 466
Ventricular assist device therapy normalizes
inducible nitric oxide synthase expression and
reduces cardiomyocyte apoptosis in the failing
human heart, 1419
Arrhythmias
See also Atrial fibrillation; Atrial flutter; Ventricular
fibrillation; Ventricular tachycardia
Effects of left ventricular assist device therapy on
ventricular arrhythmias, 1428
Idiopathic ventricular arrhythmia arising from the
mitral annulus, 877
Mortality reduction by implantable cardioverter-
defibrillators in high-risk patients with heart
failure, ischemic heart disease, and new-onset
ventricular arrhythmia, 1474
Role of transtelephonic electrocardiographic
monitoring in detecting short-term
arrhythmia recurrences after radiofrequency
ablation in patients with atrial fibrillation, 873
Spectrum and prognostic significance of
arrhythmias on ambulatory Holter
electrocardiogram in hypertrophic
cardiomyopathy, 697
36th Bethesda Conference: Task force 7:
arrhythmias, 1354
World Trade Center attack and cardiac events: fact
or fear? (letter), 1732
Year in clinical electrophysiology, 790
Arrhythmogenic right ventricular cardiomyopathy
Impact of implantable cardioverter-defibrillator
therapy on survival in autosomal-dominant
arrhythmogenic right ventricular
cardiomyopathy (ARVD5), 400
Implantable cardioverter-defibrillator therapy in
arrhythmogenic right ventricular
cardiomyopathy (editorial), 409
Noninvasive detection of myocardial fibrosis in
arrhythmogenic right ventricular
cardiomyopathy using delayed-enhancement
magnetic resonance imaging, 98
36th Bethesda Conference: Task force 4: HCM
and other cardiomyopathies, mitral valve
prolapse, myocarditis, and Marfan syndrome,
1340
Arrhythmogenic right ventricular dysplasia
Echocardiographic findings and the search for a
gold standard in patients with arrhythmogenic
right ventricular dysplasia (editorial), 866
Echocardiographic findings in patients meeting task
force criteria for arrhythmogenic right
ventricular dysplasia, 860
Arterial switch operation
Intracoronary ultrasound assessment late after the
arterial switch operation for transposition of
the great arteries, 2061
Arteriotomy
Vascular complications and arteriotomy during
percutaneous coronary procedures (letter),
2095
Aspirin
Coronary syndromes following aspirin withdrawal,
456
Highlights of the year in JACC 2004, 137
Is aspirin resistance or female gender associated
with a high incidence of myonecrosis after
nonurgent percutaneous coronary
intervention? (letter), 635
Pharmacodynamic interaction of naproxen with
low-dose aspirin in healthy subjects, 1295
Atenolol
Angiotensin II receptor blockade reduces new-onset
atrial fibrillation and subsequent stroke
compared to atenolol, 712
Atheromas
Diagnosis of thin fibrous cap atheromas by a self-
contained intravascular magnetic resonance
imaging probe in ex-vivo human aortas and
in-situ coronary arteries, 1961
Atherosclerosis
See also Coronary artery disease
Apolipoprotein CI content of triglyceride-rich
lipoproteins independently predicts early
atherosclerosis in healthy middle-aged men,
1013
Atherosclerosis of the aorta: risk factor, risk marker,
or innocent bystander? (letter), 1907
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Common PCSK9 haplotype, encompassing the
E670G coding single nucleotide
polymorphism, is a novel genetic marker for
plasma low-density-lipoprotein cholesterol
levels and severity of coronary atherosclerosis,
1611
Does shear stress modulate both plaque progression
and regression in the thoracic aorta?, 846
Endothelial progenitor obsolescence and
atherosclerotic inflammation (editorial), 1458
Increased carotid atherosclerosis in andropausal
middle-aged men, 1603
Intravascular ultrasound evidence of
angiographically silent progression in coronary
atherosclerosis predicts long-term morbidity
and mortality after cardiac transplantation,
1538
Involvement of tumor necrosis factor-related
apoptosis-inducing ligand (TRAIL) in
atherosclerosis, 1018
Long-term safety of intravascular ultrasound in
nontransplant, nonintervened, atherosclerotic
coronary arteries, 559
Plasma triglycerides and type III hyperlipidemia are
independently associated with premature
familial coronary artery disease, 1003
Primary and a half prevention—can we identify
asymptomatic subjects with high vascular risk?
(editorial), 1994
Should we screen for occult coronary artery disease
among asymptomatic patients with diabetes?,
50
Atherosclerotic plaque
Act local, act global (editorial), 1600
Angioscopic follow-up study of coronary ruptured
plaques in nonculprit lesions, 652
Detection of lipid-laden atherosclerotic plaque by
wavelet analysis of radio-frequency
intravascular ultrasound signals: in vitro
validation and preliminary in vivo application,
1954
Diffuse and active inflammation occurs in both
vulnerable and stable plaques of the entire
coronary tree, 1585
Does shear stress modulate both plaque progression
and regression in the thoracic aorta?, 846
Effect of lipid-lowering therapy with atorvastatin on
atherosclerotic aortic plaques detected by
noninvasive magnetic resonance imaging, 733
Incidence and clinical correlates of ruptured plaques
in saphenous vein grafts: an intravascular
ultrasound study, 1974
Multiple plaque rupture and C-reactive protein in
acute myocardial infarction, 1594
Picking plaques that pop. . . (editorial), 1970
Plant sterols in serum and in atherosclerotic plaques
of patients undergoing carotid
endarterectomy, 1795
Plaque rupture and intracoronary thrombus in
nonculprit vessels (editorial), 659
Volumetric quantitative analysis of tissue
characteristics of coronary plaques after statin
therapy using three dimensional integrated
backscatter intravascular ultrasound (3D IB-
IVUS), 1946
Atherothrombosis
Another look at the age-old question (editorial),
244
Increase of C-reactive protein is associated with
enhanced activation of endogenous fibrinolysis
at baseline but an impaired endothelial
fibrinolytic response after venous occlusion, 30
Persistent systemic inflammation in unstable angina
is largely unrelated to the atherothrombotic
burden, 238
Athletes
Detection of pathologic or physiologic left
ventricular remodeling in athletes (letter),
1731
36th Bethesda Conference: eligibility
recommendations for competitive athletes
with cardiovascular abnormalities, 1313
Atorvastatin
See also Statins
Additive beneficial effects of fenofibrate combined
with atorvastatin in the treatment of
combined hyperlipidemia, 1649
Atorvastatin decreases cellular proliferation and
bone matrix expression in the
hypercholesterolemic mitral valve (letter), 631
Effect of lipid-lowering therapy with atorvastatin on
atherosclerotic aortic plaques detected by
noninvasive magnetic resonance imaging, 733
Failure to protect the myocardium against ischemia/
reperfusion injury after chronic atorvastatin
treatment is recaptured by acute atorvastatin
treatment, 1287
Relative efficacy of atorvastatin 80 mg and
pravastatin 40 mg in achieving he dual goals
of low-density lipoprotein cholesterol, 1644
Atrial fibrillation
Angiotensin II inhibition and prevention of atrial
fibrillation and stroke (editorial), 720
Angiotensin II receptor blockade reduces new-onset
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compared to atenolol, 712
Are transthoracic echocardiographic parameters
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stroke? Results from the AFFIRM study,
2026
Atrial fibrillation: the ancient conundrum defies
simple solution, 1814
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vein focal firing into atrial fibrillation, 1879
Beta-blockers versus digoxin to control ventricular
rate during atrial fibrillation (letter), 1906
Cardiovascular morbidity and mortality in
hypertensive patients with a history of atrial
fibrillation, 705
Discordant atrial natriuretic peptide and brain
natriuretic peptide levels in lone atrial
fibrillation, 82
Heart rate turbulence after atrial premature beats
before spontaneous onset of atrial fibrillation,
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Highlights of the year in JACC 2004, 137
Multislice computed tomography versus intracardiac
echocardiography to evaluate the pulmonary
veins before radiofrequency catheter ablation
of atrial fibrillation, 343
N-3 fatty acids for the prevention of atrial
fibrillation after coronary artery bypass
surgery, 1723, 1723
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prospective and serial follow-up over 12
months with transesophageal
echocardiography and cerebral magnetic
resonance imaging, 1808
Preservation of the anterior fat pad and incidence
of postoperative atrial fibrillation following
coronary surgery (letter), 1308
Prevention of atrial fibrillation with angiotensin
converting enzyme inhibitors and angiotensin
receptor blockers: a meta-analysis, 1833
Rapid and stable reentry within the pulmonary vein
as a mechanism initiating paroxysmal atrial
fibrillation, 1872
Reduced atrial fibrillation incidence by angiotensin-
converting enzyme inhibitors: a possible
contributing mechanism (letter), 1144
Role of transtelephonic electrocardiographic
monitoring in detecting short-term
arrhythmia recurrences after radiofrequency
ablation in patients with atrial fibrillation, 873
36th Bethesda Conference: Task force 7:
arrhythmias, 1354
Transcatheter radiofrequency ablation of atrial
fibrillation in patients with mitral valve
prostheses and enlarged atria, 868
Ximelagatran: oral direct thrombin inhibitor as
anticoagulant therapy in atrial fibrillation, 1
Year in cardiovascular surgery, 1517
Atrial flutter
Long-term efficacy of cryo catheter ablation for the
treatment of atrial flutter, 573
Need for atrial flutter ablation following pulmonary
vein antrum isolation in patients with and
without previous cardiac surgery, 690
Separating non–isthmus- from isthmus-dependent
atrial flutter using wavefront variability, 1269
36th Bethesda Conference: Task force 7:
arrhythmias, 1354
Atrial natriuretic peptide
Discordant atrial natriuretic peptide and brain
natriuretic peptide levels in lone atrial
fibrillation, 82
Year in valvular heart disease, 111
Atrial pacing
Right atrial pacing impairs cardiac function during
resynchronization therapy, 1482
Atrial premature beats
Heart rate turbulence after atrial premature beats
before spontaneous onset of atrial fibrillation,
278
Atrial septal aneurysm
Transcatheter treatment of atrial septal aneurysm
associated with patent foramen ovale for
prevention of recurrent paradoxical embolism
in high-risk patients, 377
Atrial septal defect
Association of interatrial shunts and migraine
headaches, 489
Cardiac perforation after device closure of atrial
septal defects with the Amplatzer Septal
Occluder, 1213
Highlights of the year in JACC 2004, 137
Improvements in cardiac form and function after
transcatheter closure of secundum atrial septal
defects, 499
Long-term outcome of transcatheter secundum-type
atrial septal defect closure using Amplatzer
septal occluders, 505
36th Bethesda Conference: Task force 2: congenital
heart disease, 1326
Atrial tachycardia
Focal atrial tachycardia from the ostium of the
coronary sinus, 1488
Atrioventricular block
Reversible atrioventricular block and the Amplatzer
device (letter), 1306
36th Bethesda Conference: Task force 7:
arrhythmias, 1354
Atrioventricular junction
Transvenous cryothermal catheter ablation of re-
entry circuit located near the atrioventricular
junction in pediatric patients, 1096
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Cryo-ablation for septal tachycardia substrates in
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Automated external defibrillators
Better outcome after pediatric defibrillation dosage
than adult dosage in a swine model of
pediatric ventricular fibrillation, 786
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Autosomal-dominant hypercholesterolemia
Common PCSK9 haplotype, encompassing the
E670G coding single nucleotide
polymorphism, is a novel genetic marker for
plasma low-density-lipoprotein cholesterol
levels and severity of coronary atherosclerosis,
1611
Balloon angioplasty
Coronary stenting versus balloon angioplasty in
small vessels (letter), 323
Impact of re-coarctation following the Norwood
operation on survival in the balloon
angioplasty era, 1845
Bare-metal stents
Drug-eluting stent thrombosis, 954
Thirty-day incidence and six-month clinical
outcome of thrombotic stent occlusion after
bare-metal, sirolimus, or paclitaxel stent
implantation, 947
Treatment of saphenous vein graft lesions with
drug-eluting stents, 989
What is the risk of stent thrombosis associated with
the use of paclitaxel-eluting stents for
percutaneous coronary intervention?, 941
Beta blockers
Beta-blockers versus digoxin to control ventricular
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Left ventricular assist device support normalizes left
and right ventricular beta-adrenergic pathway
properties, 668
Beta-blockers
Three decades of clinical trials with beta-blockers
(editorial), 531
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treating patients with heart failure with a
beta-blocker?, 252
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abnormalities—general considerations, 1318
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Task force 4: HCM and other cardiomyopathies,
mitral valve prolapse, myocarditis, and Marfan
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36th Bethesda Conference: Task force 3: valvular
heart disease, 1334
Bioelectrical impedance
Changes in BNP levels and bioelectrical impedance
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versus high dose of furosemide along, in
refractory congestive heart failure, 1997
Bioprostheses
See also Prosthetic heart valves
Hemodynamic comparison of bioprostheses for
complete supraannular position in patients
with small aortic annulus, 2054
Bivalirudin
Use of bivalirudin during percutaneous coronary
intervention in patients with diabetes mellitus:
an analysis from the REPLACE-2 trial, 1932
Blood urea nitrogen
Serum blood urea nitrogen as an independent
marker of subsequent mortality among
patients with acute coronary syndromes and
normal to mildly reduced glomerular filtration
rates, 1782
Body mass index
Prognostic importance of body mass index after
complicated myocardial infarction (letter), 156
Brachial artery
Relationship between carotid artery intima-media
thickness and brachial artery flow-mediated
dilation in middle-aged healthy men, 1980
B-type natriuretic peptide
Changes in BNP levels and bioelectrical impedance
measurements after treatment with high dose
furosemide and hypertonic saline solution
versus high dose of furosemide along, in
refractory congestive heart failure, 1997
Community screening for left ventricular systolic
dysfunction using plasma and urinary
natriuretic peptides, 1043
Discordant atrial natriuretic peptide and brain
natriuretic peptide levels in lone atrial
fibrillation, 82
Efficacy of brain natriuretic peptide levels in
differentiating constrictive pericarditis from
restrictive cardiomyopathy, 1901
Incremental predictive power of B-type natriuretic
peptide and tissue Doppler echocardiography
in the prognosis of patients with congestive
heart failure, 1223
Obesity and B-type natriuretic peptide levels in
heart failure (letter), 967
Relationship between B-type natriuretic peptides
and pulmonary capillary wedge pressure in the
intensive care unit, 1667
Serial analyses of N-terminal pro-B-type natriuretic
peptide in patients with non–ST-segment
elevation acute coronary syndromes, 533
Warning! Context-sensitive data (editorial), 542
Year in valvular heart disease, 111
Candesartan
Effects of candesartan on cardiac sympathetic nerve
activity in patients with congestive heart
failure and preserved left ventricular ejection
fraction, 661
Carbon monoxide poisoning
Cardiovascular manifestations of moderate to severe
carbon monoxide poisoning, 1513
Cardiac allograft vasculopathy
Multicenter intravascular ultrasound validation
study among heart transplant recipients, 1532
Cardiac magnetic resonance
Cardiac magnetic resonance imaging training
(letter), 1307
Cardiac magnetic resonance training: how we can
get there from here (letter), 1306
Cardiovascular magnetic resonance for the diagnosis
of acute myocarditis: prospects for detecting
myocardial inflammation, 1824
Diagnostic performance of cardiovascular magnetic
resonance in patients with suspected acute
myocarditis: comparison of different
approaches, 1816
Does subclinical hypothyroidism affect cardiac
pump performance?, 439
Effect of lipid-lowering therapy with atorvastatin
on atherosclerotic aortic plaques detected by
noninvasive magnetic resonance imaging,
733
Feasibility of tissue magnetic resonance imaging,
1109
Infarct morphology identifies patients with substrate
for sustained ventricular tachycardia, 1104
Late gadolinium-enhanced magnetic resonance
imaging in acute and chronic myocardial
infarction, 901
Noninvasive detection of myocardial fibrosis in
arrhythmogenic right ventricular
cardiomyopathy using delayed-enhancement
magnetic resonance imaging, 98
Noninvasive diagnosis of coronary artery disease in
patients with heart failure and systolic
dysfunction of uncertain etiology, using late
gadolinium-enhanced cardiovascular magnetic
resonance, 743
Pacemaker complication during magnetic resonance
imaging (letter), 161
Quantitative measurement of infarct size by
contrast-enhanced magnetic resonance
imaging early after acute myocardial
infarction, 544
Relationship of irreversible myocardial injury to
troponin I and creatine kinase-MB elevation
after coronary artery bypass surgery: insights
from cardiovascular magnetic resonance
imaging (letter), 629
Cardiac output
Use of live three-dimensional Doppler
echocardiography in the measurement of
cardiac output, 433
Cardiac perforation
Cardiac perforation after device closure of atrial
septal defects with the Amplatzer Septal
Occluder, 1213
Cardiac rehabilitation
Cardiac rehabilitation after myocardial infarction in
the community (letter), 1909
Cardiac resynchronization therapy
Cardiac resynchronization therapy, central sleep
apnea, and Cheyne-Stokes respiration in
chronic heart failure patients (letter), 633
Cardiac resynchronization therapy 101 (editorial),
70
Noninvasive visualization of the cardiac venous
system using multislice computed
tomography, 749
Novel tool to assess systolic asynchrony and identify
responders of cardiac resynchronization
therapy by tissue synchronization imaging,
677
Right atrial pacing impairs cardiac function during
resynchronization therapy, 1482
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Ventricular asynchrony predicts a better outcome in
patients with chronic heart failure receiving
cardiac resynchronization therapy, 65
Cardiac sarcoidosis
Evaluation of the accuracy of gadolinium-enhanced
cardiovascular magnetic resonance in the
diagnosis of cardiac sarcoidosis, 1683
Cardiac surgery
See also Surgery
Intraoperative crossover: the well-kept surgical
secret to apparent surgical success, 1529
Need for atrial flutter ablation following pulmonary
vein antrum isolation in patients with and
without previous cardiac surgery, 690
Cardiac sympathetic nerve activity
Effects of candesartan on cardiac sympathetic nerve
activity in patients with congestive heart
failure and preserved left ventricular ejection
fraction, 661
Cardiac transplantation
See Heart transplantation
Cardiogenic shock
Does inhaled nitric oxide support the
hemodynamics of spontaneous breathing
patients with cardiogenic shock related to
right ventricular myocardial infarction?
(letter), 965
Cardiologists
Cardiologist in the carotids (letter), 326
Morphing of cardiovascular specialists, 960
Note on the history of cardiology: Dr. Otto Klein,
1881 to 1968, 446
Quality of care reigns supreme: cardiologist at the
helm, Wolk
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Year in cardiovascular surgery, 1517
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Year in interventional cardiology, 1117
Cardiomyocytes
Ventricular assist device therapy normalizes
inducible nitric oxide synthase expression and
reduces cardiomyocyte apoptosis in the failing
human heart, 1419
Cardiomyopathy
See also Dilated cardiomyopathy; Hypertrophic
cardiomyopathy
Early recovery of impaired coronary flow reserve by
carvedilol therapy in patients with idiopathic
dilated cardiomyopathy: a serial transthoracic
Doppler echocardiographic study (letter), 318
Impact of implantable cardioverter-defibrillator
therapy on survival in autosomal-dominant
arrhythmogenic right ventricular
cardiomyopathy (ARVD5), 400
Implantable cardioverter-defibrillator therapy in
arrhythmogenic right ventricular
cardiomyopathy (editorial), 409
Noninvasive detection of myocardial fibrosis in
arrhythmogenic right ventricular
cardiomyopathy using delayed-enhancement
magnetic resonance imaging, 98
Cardioprotection
Cyclooxygenase-1 mediates the final stage of
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1406
Ethnicity
Ethnic differences in the prognostic value of stress
technetium-99m tetrofosmin gated single-
photon emission computed tomography
myocardial perfusion imaging, 1494
Evidence-based guidelines
Should the lack of feasibility of conducting
controlled trials influence evidence-based
guidelines (letter), 810
Exercise
Benefit of an exercise program before myocardial
infarction (editorial), 939
Increased skeletal muscle amino acid release with
light exercise in deconditioned patients with
heart failure (letter), 158
Prior exercise training improves the outcome of
acute myocardial infarction in the rat, 931
Exercise testing
Cardiopulmonary exercise testing in patients with
heart failure (letter), 163
Comparison of treadmill exercise versus
dipyridamole stress with myocardial perfusion
imaging using rubidium-82 positron emission
tomography, 1227
Extracellular matrix
Apparently normal mitral valves in patients with
heart failure demonstrate biochemical and
structural derangements, 54
Factor XIII valine 34 leu polymorphism
Pharmacogenetic effect of factor XIII Valine 34 leu
polymorphism on fibrinolytic therapy for acute
myocardial infarction, 25
Fast ventricular tachycardias
Fast ventricular tachycardias in patients with
implantable cardioverter-defibrillators: efficacy
and safety of antitachycardia pacing, 460
Fat pads
Preservation of the anterior fat pad and incidence
of postoperative atrial fibrillation following
coronary surgery (letter), 1308
Femoropopliteal stenting
Prevalence and clinical impact of stent fractures
after femoropopliteal stenting, 312
Fenofibrate
Additive beneficial effects of fenofibrate combined
with atorvastatin in the treatment of
combined hyperlipidemia, 1649
Fibrates
Efficacy and safety of high-density lipoprotein
cholesterol-increasing compounds, 185
Fibrin sealant
Transplantation in fibrin sealant (letter), 1734
Fibrinolysis
Increase of C-reactive protein is associated with
enhanced activation of endogenous fibrinolysis
at baseline but an impaired endothelial
fibrinolytic response after venous occlusion, 30
Fibrinolytic therapy
Association of smoking with improved myocardial
perfusion and the angiographic
characterization of myocardial tissue perfusion
after fibrinolytic therapy for ST-segment
elevation myocardial infarction (letter), 321
Pharmacogenetic effect of factor XIII Valine 34 leu
polymorphism on fibrinolytic therapy for acute
myocardial infarction, 25
Fish intake
Fish intake and risk of incident heart failure, 2015
Flow-mediated dilatation
Is the association between flow-mediated dilatation
and cardiovascular risk limited to low risk
populations?, 1987
Relationship between carotid artery intima-media
thickness and brachial artery flow-mediated
dilation in middle-aged healthy men, 1980
Fludrocortisone
Effectiveness of fludrocortisone and salt in
preventing syncope recurrence in children, 484
Fluorodeoxyglucose
Increased [18F]fluorodeoxyglucose accumulation in
right ventricular free wall in patients with
pulmonary hypertension and the effect of
epoprostenol, 1850
Folic acid
High-dose folic acid acutely improves coronary
vasodilator function in patients with coronary
artery disease, 1580
Fontan operation
36th Bethesda Conference: Task force 2: congenital
heart disease, 1326
Free fatty acids
Increased skeletal muscle amino acid release with
light exercise in deconditioned patients with
heart failure (letter), 158
Furosemide
Changes in BNP levels and bioelectrical impedance
measurements after treatment with high dose
furosemide and hypertonic saline solution
versus high dose of furosemide along, in
refractory congestive heart failure, 1997
Gadolinium-enhanced magnetic resonance imaging
Evaluation of the accuracy of gadolinium-enhanced
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cardiovascular magnetic resonance in the
diagnosis of cardiac sarcoidosis, 1683
Late gadolinium-enhanced magnetic resonance
imaging in acute and chronic myocardial
infarction, 901
Noninvasive diagnosis of coronary artery disease in
patients with heart failure and systolic
dysfunction of uncertain etiology, using late
gadolinium-enhanced cardiovascular magnetic
resonance, 743
Gender
See also Women
Gender and myocardial salvage after reperfusion
treatment in acute myocardial infarction, 828
Gender differences in endothelial tissue-type
plasminogen activator release in middle-aged
adults (letter), 1547
Gender disparities in the diagnosis and treatment
of non–ST-segment elevation acute coronary
syndromes, 832
Gender-based outcomes after paclitaxel-eluting
stent implantation in patients with coronary
artery disease, 1180
Gender-specific impact of diabetes and myocardial
infarction at baseline and during follow-up on
mortality from all causes and coronary heart
disease, 1413
Hemodynamic and autonomic effects of smokeless
tobacco in healthy young men, 910
Is aspirin resistance or female gender associated
with a high incidence of myonecrosis after
nonurgent percutaneous coronary
intervention? (letter), 635
Seven-year follow-up after dobutamine stress
echocardiography, 93
Gene delivery
Use of ultrasound contrast agents for gene or drug
delivery in cardiovascular medicine, 329
Genetics
Clinical and genetic issues in familial dilated
cardiomyopathy, 969
Glomerular filtration rate
Serum blood urea nitrogen as an independent
marker of subsequent mortality among
patients with acute coronary syndromes and
normal to mildly reduced glomerular filtration
rates, 1782
Glutathione peroxidase-1
Glutathione peroxidase-1 and homocysteine for
cardiovascular risk prediction, 1631
Glycemic control
Improvement or cardiovascular risk markers by
pioglitazone is independent from glycemic
control—results from the Pioneer study, 1925
Glycoprotein IIb/IIIa inhibitors
Risk factors for the development of retroperitoneal
hematoma after percutaneous coronary
intervention in the era of glycoprotein IIb/IIIa
inhibitors and vascular closure devices, 363
Headaches
Association of interatrial shunts and migraine
headaches, 489
Migraine headache relief after transcatheter closure
of patent foramen ovale, 493
Transcatheter closure of patent foramen ovale for
migraine prophylaxis (editorial), 496
Health care
Big chill: the deleterious effects of public reporting
on access to health care for the sickest
patients, 1767
Immigration policy and healthcare, 1729
Quality of care reigns supreme: cardiologist at the
helm, 1913
Health insurance
Health insurance and cardiac transplantation, 1388
Health-related quality of life
Health-related quality of life after interventional or
conservative strategy in patients with unstable
angina or non–ST-segment elevation
myocardial infarction, 221
Heart failure
Apparently normal mitral valves in patients with
heart failure demonstrate biochemical and
structural derangements, 54
Angiotensin-converting enzyme inhibitors and
outcome among patients with heart failure
and renal insufficiency: need for a prospective
study(letter), 1905
Cardiac resynchronization therapy, central sleep
apnea, and Cheyne-Stokes respiration in
chronic heart failure patients (letter), 633
Cardiac resynchronization therapy 101 (editorial), 70
Cardiopulmonary exercise testing in patients with
heart failure (letter), 163
Changes in BNP levels and bioelectrical impedance
measurements after treatment with high dose
furosemide and hypertonic saline solution
versus high dose of furosemide along, in
refractory congestive heart failure, 1997
Community screening for left ventricular systolic
dysfunction using plasma and urinary
natriuretic peptides, 1043
Contribution of ischemic mitral regurgitation to
congestive heart failure after myocardial
infarction, 260
Cross-sectional relations of electrocardiographic QRS
duration to left ventricular dimensions, 685
Cystatin-C and mortality in elderly persons with
heart failure, 268
Different effects of high cholesterol diet on
ischemic cardiac dysfunction and remodeling
induced by coronary stenosis and by coronary
occlusion, 2078
Echocardiographic predictors of morbidity and
mortality in patients with advanced heart
failure, 1064
Effect of kidney transplantation on left ventricular
systolic dysfunction and congestive heart
failure in patients with end-stage renal
disease, 1051
Effects of candesartan on cardiac sympathetic nerve
activity in patients with congestive heart
failure and preserved left ventricular ejection
fraction, 661
Electrocardiography and Doppler echocardiography
for risk stratification in patients with chronic
heart failure, 1072
Fish intake and risk of incident heart failure, 2015
Further aspects of anemia, heart failure, and
erythropoietin (letter), 1549
Heart failure training: care for older adults with
chronic heart failure (letter), 2096
Highlights of the 2004 scientific sessions of the
Heart Failure Society of America, Toronto,
Canada, September 12 to 15, 2004, 617
Highlights of the year in JACC 2004, 137
Improvement of heart failure after renal
transplantation (editorial), 1061
Improving the outcomes of heart failure care
(editorial), 1665
Increased skeletal muscle amino acid release with
light exercise in deconditioned patients with
heart failure (letter), 158
Incremental predictive power of B-type natriuretic
peptide and tissue Doppler echocardiography
in the prognosis of patients with congestive
heart failure, 1223
Inducible nitric oxide synthase in severe human
heart failure (editorial), 1425
Inflammation, as measured by the erythrocyte
sedimentation rate, is an independent
predictor for development of heart failure,
1803
Influence of pretreatment systolic blood pressure on
benefit from carvedilol in severe chronic heart
failure patients (letter), 809
Inhibition of awake sympathetic nerve activity of
heart failure patients with obstructive sleep
apnea by nocturnal continuous positive airway
pressure, Usui
Is mitral regurgitation a viable treatment target in
heart failure? (editorial), 388
Mitral valve abnormalities in congestive heart
failure (editorial), 62
Mortality reduction by implantable cardioverter-
defibrillators in high-risk patients with heart
failure, ischemic heart disease, and new-onset
ventricular arrhythmia, 1474
Noninvasive diagnosis of coronary artery disease in
patients with heart failure and systolic
dysfunction of uncertain etiology, using late
gadolinium-enhanced cardiovascular magnetic
resonance, 743
Noninvasive home telemonitoring for patients with
heart failure at high risk of recurrent
admission and death, 1654
Obesity and B-type natriuretic peptide levels in
heart failure (letter), 967
Recent hypertension trials, 813
Targeted inhibition of ARK1-associated
phosphoinositide 3-kinase activity preserves
-adrenergic receptor signaling and prolongs
survival in heart failure induced by
calsequestrin overexpression, 1863
Torrent or torment from the tubules? Challenge of
the cardio-renal connections (editorial), 2004
Treating sleep apnea in heart failure patients:
promises but still no prizes (editorial), 2012
Ventricular assist device therapy normalizes
inducible nitric oxide synthase expression and
reduces cardiomyocyte apoptosis in the failing
human heart, 1419
Ventricular asynchrony predicts a better outcome in
patients with chronic heart failure receiving
cardiac resynchronization therapy, 65
What resting heart rate should one aim for when
treating patients with heart failure with a
beta-blocker?, 252
Year in cardiovascular surgery, 1517
Heart rate
Heart rate turbulence after atrial premature beats
before spontaneous onset of atrial fibrillation,
278
What resting heart rate should one aim for when
treating patients with heart failure with a
beta-blocker?, 252
Heart transplantation
Coronary stenosis detection by 16-slice computed
tomography in heart transplant patients:
comparison with conventional angiography
and impact on clinical management, 1827
Health insurance and cardiac transplantation, 1388
Highlights of the year in JACC 2004, 137
Improved outcomes of pediatric dilated
cardiomyopathy and heart transplantation
(letter), 1733
Intravascular ultrasound evidence of
angiographically silent progression in coronary
atherosclerosis predicts long-term morbidity
and mortality after cardiac transplantation,
1538
2115JACC Vol. 45, No. 12, 2005 Subject Index: Volume 45
June 21, 2005:2106–28
Multicenter intravascular ultrasound validation
study among heart transplant recipients, 1532
Helicobacter pylori
Association of Helicobacter pylori infection with
systemic inflammation and endothelial
dysfunction in healthy male subjects, 1219
Hematocrit
Is there an optimal hematocrit value for cardiac
patients (letter), 1549
Hemodynamics
Does inhaled nitric oxide support the
hemodynamics of spontaneous breathing
patients with cardiogenic shock related to
right ventricular myocardial infarction?
(letter), 965
Hemodynamic and autonomic effects of smokeless
tobacco in healthy young men, 910
Hemodynamic comparison of bioprostheses for
complete supraannular position in patients
with small aortic annulus, 2054
Quantitative relation between hemodynamic changes
during intravenous adenosine infusion and the
magnitude of coronary hyperemia, 553
Hibernating myocardium
Hibernating myocardium, apoptosis, and a simple
mathematical task (letter), 466
Highlights of the year in JACC 2004, 137
High-density lipoprotein
Efficacy and safety of high-density lipoprotein
cholesterol-increasing compounds, 185
High-intensity transient signals
Detection of embolic particles with the Doppler
guide wire during coronary intervention in
patients with acute myocardial infarction, 212
Holter electrocardiography
Spectrum and prognostic significance of
arrhythmias on ambulatory Holter
electrocardiogram in hypertrophic
cardiomyopathy, 697
Home telemonitoring
Noninvasive home telemonitoring for patients with
heart failure at high risk of recurrent
admission and death, 1654
Homocysteine
Glutathione peroxidase-1 and homocysteine for
cardiovascular risk prediction, 1631
Hydroxyfasudil
Beneficial effect of hydroxyfasudil, a specific rho-
kinase inhibitor, on ischemia/reperfusion
injury in canine coronary microcirculation in
vivo, 599
Hypercholesterolemia
Atorvastatin decreases cellular proliferation and
bone matrix expression in the
hypercholesterolemic mitral valve (letter), 631
CD40 ligand enhances monocyte tissue factor
expression and thrombin generation via
oxidative stress in patients with
hypercholesterolemia, 35
Common PCSK9 haplotype, encompassing the
E670G coding single nucleotide polymorphism,
is a novel genetic marker for plasma low-
density-lipoprotein cholesterol levels and severity
of coronary atherosclerosis, 1611
What promise does PCSK9 hold? (editorial), 1620
Hyperemia
Quantitative relation between hemodynamic changes
during intravenous adenosine infusion and the
magnitude of coronary hyperemia, 553
Hyperglycemia
Hyperglycemia is an important predictor of
impaired coronary flow before reperfusion
therapy in ST-segment elevation myocardial
infarction, 999
Hyperlipidemia
Additive beneficial effects of fenofibrate combined
with atorvastatin in the treatment of
combined hyperlipidemia, 1649
Plasma triglycerides and type III hyperlipidemia are
independently associated with premature
familial coronary artery disease, 1003
Relative efficacy of atorvastatin 80 mg and
pravastatin 40 mg in achieving he dual goals
of low-density lipoprotein cholesterol, 1644
Hypertension
Cardiovascular morbidity and mortality in
hypertensive patients with a history of atrial
fibrillation, 705
Impact of pulmonary hypertension on the outcomes
of noncardiac surgery, 1691
Recent hypertension trials, 813
36th Bethesda Conference: Task force 5: systemic
hypertension, 1346
Hypertrophic cardiomyopathy
Adenosine monophosphate-activated protein kinase
disease mimicks hypertrophic cardiomyopathy
and Wolff-Parkinson-White syndrome, 922
Multicenter study of the efficacy and safety of
disopyramide in obstructive hypertrophic
cardiomyopathy, 1251
Prognostic importance of left ventricular outflow
obstruction in hypertrophic cardiomyopathy
varies in relation to the severity of symptoms,
1076
Spectrum and prognostic significance of
arrhythmias on ambulatory Holter
electrocardiogram in hypertrophic
cardiomyopathy, 697
36th Bethesda Conference: Task force 4: HCM
and other cardiomyopathies, mitral valve
prolapse, myocarditis, and Marfan syndrome,
1340
Hypothyroidism
Does subclinical hypothyroidism affect cardiac
pump performance?, 439
Idiopathic dilated cardiomyopathy
Clinical and genetic issues in familial dilated
cardiomyopathy, 969
Early recovery of impaired coronary flow reserve by
carvedilol therapy in patients with idiopathic
dilated cardiomyopathy: a serial transthoracic
Doppler echocardiographic study (letter), 318
Imaging
See also Computed tomography; Echocardiography;
Magnetic resonance imaging; Single-photon
emission computed tomography
Growth of diagnostic imaging services, 2093
President’s page: imaging: not a black and white
issue, 627
Immigration
Immigration policy and healthcare, 1729
Implantable cardioverter-defibrillators
Care disparities (editorial), 79
Defibrillation thresholds testing of implantable
cardioverter-defibrillators at implantation
(letter), 468
Depression as a predictor for appropriate shocks
among patients with implantable cardioverter-
defibrillators, 1090
Fast ventricular tachycardias in patients with
implantable cardioverter-defibrillators: efficacy
and safety of antitachycardia pacing, 460
Growing mismatch between patient longevity and
the service life of implantable cardioverter-
defibrillators, Hauser
Impact of implantable cardioverter-defibrillator
therapy on survival in autosomal-dominant
arrhythmogenic right ventricular
cardiomyopathy (ARVD5), 400
Implantable cardioverter-defibrillator therapy in
arrhythmogenic right ventricular
cardiomyopathy (editorial), 409
Mortality reduction by implantable cardioverter-
defibrillators in high-risk patients with heart
failure, ischemic heart disease, and new-onset
ventricular arrhythmia, 1474
Patient alert and cardiac defibrillators (letter), 966
Severe symptomatic tricuspid valve regurgitation
due to permanent pacemaker or implantable
cardioverter defibrillator leads, 1672
Trends in implantable cardioverter-defibrillator
racial disparity, 72
Inducible nitric oxide synthase
Inducible nitric oxide synthase in severe human
heart failure (editorial), 1425
Ventricular assist device therapy normalizes
inducible nitric oxide synthase expression and
reduces cardiomyocyte apoptosis in the failing
human heart, 1419
Infarct
High serum erythropoietin level is associated with
smaller infarct size in patients with acute
myocardial infarction who undergo successful
primary percutaneous coronary intervention,
1406
Infarct morphology identifies patients with substrate
for sustained ventricular tachycardia, 1104
Prodromal angina limits infarct size in the setting
of acute anterior myocardial infarction treated
with primary percutaneous intervention
(letter), 1545
Infarction
See Myocardial infarction
Infective endocarditis
Year in valvular heart disease, 111
Inflammation
Act local, act global (editorial), 1600
Association of Helicobacter pylori infection with
systemic inflammation and endothelial
dysfunction in healthy male subjects, 1219
Cardiovascular magnetic resonance for the diagnosis
of acute myocarditis: prospects for detecting
myocardial inflammation, 1824
Diffuse and active inflammation occurs in both
vulnerable and stable plaques of the entire
coronary tree, 1585
Effects of physical activity on serum C-reactive
protein and inflammatory markers, 1563
Endothelial progenitor obsolescence and
atherosclerotic inflammation (editorial), 1458
Inflammation, as measured by the erythrocyte
sedimentation rate, is an independent
predictor for development of heart failure,
1803
Persistent systemic inflammation in unstable angina
is largely unrelated to the atherothrombotic
burden, 238
Relationship between inflammation and venous
thromboembolism as studied by microparticle
assessment in plasma (editorial), 1472
Inflammatory markers
Primary and a half prevention—can we identify
asymptomatic subjects with high vascular risk?
(editorial), 1994
In-stent restenosis
Simple, inexpensive, rapid, and accurate preclinical
model for in-stent restenosis (letter), 1310
Intensive care unit
Relationship between B-type natriuretic peptides
and pulmonary capillary wedge pressure in the
intensive care unit, 1667
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Interatrial shunts
Association of interatrial shunts and migraine
headaches, 489
Interventional cardiology
Association of a negative residual stenosis following
rescue/adjunctive percutaneous coronary
intervention with impaired myocardial
perfusion and adverse outcomes among ST-
segment elevation myocardial infarction
patients, 357
Detection of embolic particles with the Doppler
guide wire during coronary intervention in
patients with acute myocardial infarction, 212
Direct stenting of native de novo coronary artery
lesions with the sirolimus-eluting stent, 10
Economic effects of prolonged clopidogrel therapy
after percutaneous coronary intervention, 369
Impact of diabetes mellitus on myocardial perfusion
after primary angioplasty in patients with
acute myocardial infarction, 508
Intravascular ultrasound-guided treatment for
angiographically indeterminate left main
coronary artery disease, 204
Multiple overlapping drug-eluting stents to treat
diffuse disease of the left anterior descending
coronary artery, 1570
Predictive factors for ischemic target vessel
revascularization in the Prevention of
Restenosis with Tranilast and its Outcomes
(PRESTO) trial, 198
Pressure-derived measurement of coronary flow
reserve, 216
Prospective randomized comparison between
paclitaxel and sirolimus stents in the real
world of interventional cardiology, 308
Relation of dosing to clopidogrel responsiveness
and the incidence of high post-treatment
platelet aggregation in patients undergoing
coronary stenting, 1392
Risk factors for the development of retroperitoneal
hematoma after percutaneous coronary
intervention in the era of glycoprotein IIb/IIIa
inhibitors and vascular closure devices, 363
Sirolimus-eluting stent implantation for unprotected
left main coronary artery stenosis, 351
Treatment of saphenous vein graft lesions with
drug-eluting stents, 989
Year in interventional cardiology, 1117
Intima-media thickness
Andropause and intima media thickness (editorial),
1609
Increased carotid atherosclerosis in andropausal
middle-aged men, 1603
Relationship between carotid artery intima-media
thickness and brachial artery flow-mediated
dilation in middle-aged healthy men, 1980
Intracoronary thrombus
Plaque rupture and intracoronary thrombus in
nonculprit vessels (editorial), 659
Intracoronary ultrasound
Intracoronary ultrasound assessment late after the
arterial switch operation for transposition of
the great arteries, 2061
Intravascular ultrasound
Detection of lipid-laden atherosclerotic plaque by
wavelet analysis of radio-frequency intravascular
ultrasound signals: in vitro validation and
preliminary in vivo application, 1954
Incidence and clinical correlates of ruptured plaques
in saphenous vein grafts: an intravascular
ultrasound study, 1974
Intravascular ultrasound evidence of
angiographically silent progression in coronary
atherosclerosis predicts long-term morbidity
and mortality after cardiac transplantation,
1538
Intravascular ultrasound-guided treatment for
angiographically indeterminate left main
coronary artery disease, 204
Long-term safety of intravascular ultrasound in
nontransplant, nonintervened, atherosclerotic
coronary arteries, 559
Multicenter intravascular ultrasound validation
study among heart transplant recipients, 1532
Polymer-based paclitaxel-eluting stents reduce in-
stent neointimal tissue proliferation, 1201
Stent underexpansion and residual reference
segment stenosis are related to stent
thrombosis after sirolimus-eluting stent
implantation, 995
Volumetric quantitative analysis of tissue
characteristics of coronary plaques after statin
therapy using three dimensional integrated
backscatter intravascular ultrasound (3D IB-
IVUS), 1946
Ischemia
Antagonism of selectin function attenuates
microvascular platelet deposition and platelet-
mediated myocardial injury after transient
ischemia, 293
Beneficial effect of hydroxyfasudil, a specific rho-
kinase inhibitor, on ischemia/reperfusion injury
in canine coronary microcirculation in vivo, 599
Role of collateral blood flow in the apparent
disparity between the extent of abnormal wall
thickening and perfusion defect size during
acute myocardial infarction and demand
ischemia, 565
Ischemia/reperfusion injury
Failure to protect the myocardium against ischemia/
reperfusion injury after chronic atorvastatin
treatment is recaptured by acute atorvastatin
treatment, 1287
Ischemic heart disease
Mortality reduction by implantable cardioverter-
defibrillators in high-risk patients with heart
failure, ischemic heart disease, and new-onset
ventricular arrhythmia, 1474
Ischemic mitral regurgitation
Contribution of ischemic mitral regurgitation to
congestive heart failure after myocardial
infarction, 260
Quantitation of mitral valve tenting in ischemic
mitral regurgitation by transthoracic real-time
three-dimensional echocardiography, 763
Isthmus-dependent atrial flutter
Separating non–isthmus- from isthmus-dependent
atrial flutter using wavefront variability, 1269
JACC
Highlights of the year in JACC 2004, 137
JT interval
Dietary linolenic acid and adjusted QT and JT
intervals in the National Heart, Lung, and
Blood Institute Family Heart Study, 1716
Kawasaki disease
36th Bethesda Conference: Task force 2: congenital
heart disease, 1326
Kidney(s)
Torrent or torment from the tubules? Challenge of
the cardio-renal connections (editorial), 2004
Kidney transplantation
Effect of kidney transplantation on left ventricular
systolic dysfunction and congestive heart
failure in patients with end-stage renal
disease, 1051
Improvement of heart failure after renal
transplantation (editorial), 1061
Left anterior descending coronary artery
Evaluation of flow in the left anterior descending
coronary artery but not in the left internal
mammary artery graft predicts significant
stenosis of the arterial conduit, 424
Multiple overlapping drug-eluting stents to treat
diffuse disease of the left anterior descending
coronary artery, 1570
Outcomes of paclitaxel-eluting stent implantation
in patients with stenosis of the left anterior
descending coronary artery, 1186
Left atrial appendage
Effects of percutaneous left atrial appendage
transcatheter occlusion (PLAATO) on left
atrial structure and function (letter), 634
Left atrial scarring
Pre-existent left atrial scarring in patients
undergoing pulmonary vein antrum isolation,
285
Left atrial volume
Diastolic dysfunction and left atrial volume, 87
Left atrium
Effects of percutaneous left atrial appendage
transcatheter occlusion (PLAATO) on left
atrial structure and function (letter), 634
Left bundle branch block
36th Bethesda Conference: Task force 7:
arrhythmias, 1354
Left internal mammary artery graft
Evaluation of flow in the left anterior descending
coronary artery but not in the left internal
mammary artery graft predicts significant
stenosis of the arterial conduit, 424
Year in cardiovascular surgery, 1517
Left main coronary artery
Intravascular ultrasound-guided treatment for
angiographically indeterminate left main
coronary artery disease, 204
Sirolimus-eluting stent implantation for
unprotected left main coronary artery stenosis,
351
Left ventricle
Cross-sectional relations of electrocardiographic
QRS duration to left ventricular dimensions,
685
Improvements in cardiac form and function after
transcatheter closure of secundum atrial septal
defects, 499
Left ventricular assist device support normalizes left
and right ventricular beta-adrenergic pathway
properties, 668
Left ventricular assist device
See also Ventricular assist devices
Effects of left ventricular assist device therapy on
ventricular arrhythmias, 1428
Left ventricular assist device malfunction, 1435
Left ventricular assist device support normalizes left
and right ventricular beta-adrenergic pathway
properties, 668
Safety and feasibility trial of the MicroMed
DeBakey ventricular assist device as a bridge
to transplantation, 962
Left ventricular asynchrony
Detection of left ventricular asynchrony in patients
with right bundle branch block after repair of
tetralogy of Fallot using tissue-Doppler
imaging-derived strain, 915
Left ventricular dilation
Radiofrequency catheter ablation of premature
ventricular complexes from right ventricular
outflow tract improves left ventricular dilation
and clinical status in patients without
structural heart disease, 1259
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Left ventricular dysfunction
Angiotensin-converting enzyme inhibitor as a risk
factor for the development of anemia, and the
impact of incident anemia on mortality in
patients with left ventricular dysfunction, 391
Effect of perindopril on the onset and progression
of left ventricular dysfunction in Duchenne
muscular dystrophy, 855
Is mitral regurgitation a viable treatment target in
heart failure? (editorial), 388
Long-term survival and functional results after
aortic valve replacement in asymptomatic
patients with chronic severe aortic
regurgitation and left ventricular dysfunction,
1025
Left ventricular ejection fraction
Effects of candesartan on cardiac sympathetic nerve
activity in patients with congestive heart
failure and preserved left ventricular ejection
fraction, 661
Left ventricular outflow obstruction
Prognostic importance of left ventricular outflow
obstruction in hypertrophic cardiomyopathy
varies in relation to the severity of symptoms,
1076
Left ventricular remodeling
Detection of pathologic or physiologic left
ventricular remodeling in athletes (letter),
1731
Left ventricular support
An expandable percutaneous catheter pump for left
ventricular support: proof of concept, 1857
Left ventricular systolic dysfunction
Community screening for left ventricular systolic
dysfunction using plasma and urinary
natriuretic peptides, 1043
Effect of kidney transplantation on left ventricular
systolic dysfunction and congestive heart
failure in patients with end-stage renal
disease, 1051
Impact of mitral valve annuloplasty on mortality
risk in patients with mitral regurgitation and
left ventricular systolic dysfunction, 381
Left ventricular systolic function
Independent and incremental prognostic value of
early mitral annulus velocity in patients with
impaired left ventricular systolic function, 272
Letters to the editor
Absence of acute effects of angiotensin II on atrial
electrophysiology in humans, 154
Advantage of percutaneous coronary intervention
over medical therapy in angina relief and the
placebo effect, 327
Association between renal insufficiency,
pharmacotherapy, and outcomes in, 6427
patients with heart failure and coronary artery
disease, 1905
Atherosclerosis of the aorta: risk factor, risk marker,
or innocent bystander? (letter), 1907
Cardiac complications of vaccines, 1309
Cardiac magnetic resonance imaging training, 1307
Cardiac magnetic resonance training: how we can
get there from here, 1306
Cardiac rehabilitation after myocardial infarction in
the community, 1909
Cardiac resynchronization therapy, central sleep
apnea, and Cheyne-Stokes respiration in
chronic heart failure patients, 633
Cardiologist in the carotids, 326
Cardiopulmonary exercise testing in patients with
heart failure, 163
Cautious interpretation of data regarding
myopericarditis associated with smallpox
vaccination, 160
Conflation of empiric and nonempiric truths in
cardiovascular guidelines, 1551
Coronary stenting versus balloon angioplasty in
small vessels, 323
Defibrillation thresholds testing of implantable
cardioverter-defibrillators at implantation, 468
Definition of failed lysis may have influenced
outcome in the MERLIN trial, 808
Detection of pathologic or physiologic left
ventricular remodeling in athletes, 1731
Differential mortality risk of post-procedural
creatine kinase-MB elevation following
successful versus unsuccessful stent procedures,
1908
Does inhaled nitric oxide support the
hemodynamics of spontaneous breathing
patients with cardiogenic shock related to
right ventricular myocardial infarction?, 965
Effects of percutaneous left atrial appendage
transcatheter occlusion (PLAATO) on left
atrial structure and function, 634
Further aspects of anemia, heart failure, and
erythropoietin, 1549
Gender differences in endothelial tissue-type
plasminogen activator release in middle-aged
adults, 1547
Heart failure training: care for older adults with
chronic heart failure, 2096
Hibernating myocardium, apoptosis, and a simple
mathematical task, 466
Improved outcomes of pediatric dilated
cardiomyopathy and heart transplantation,
1733
Increased skeletal muscle amino acid release with
light exercise in deconditioned patients with
heart failure, 158
Influence of pretreatment systolic blood pressure on
benefit from carvedilol in severe chronic heart
failure patients, 809
Is aspirin resistance or female gender associated
with a high incidence of myonecrosis after
nonurgent percutaneous coronary
intervention?, 635
Is there an optimal hematocrit value for cardiac
patients, 1549
Omega-3 fatty acids for secondary prevention, 1552
Optimal lipids, statins, and dementia, 963
Optimal low-density lipoprotein is 50 to 70 mg/dl,
1732
Pacemaker complication during magnetic resonance
imaging, 161
Patient alert and cardiac defibrillators, 966
Preservation of the anterior fat pad and incidence
of postoperative atrial fibrillation following
coronary surgery, 1308
Prodromal angina limits infarct size in the setting
of acute anterior myocardial infarction treated
with primary percutaneous intervention, 1545
Prognostic importance of body mass index after
complicated myocardial infarction, 156
Proper conduct of Valsalva maneuver for the
detection of patent foramen ovale, 1145
Reduced atrial fibrillation incidence by angiotensin-
converting enzyme inhibitors: a possible
contributing mechanism, 1144
Rescue angioplasty—The MERLIN trial, 806
Reversible atrioventricular block and the Amplatzer
device, 1306
Should the lack of feasibility of conducting
controlled trials influence evidence-based
guidelines, 810
Simple, inexpensive, rapid, and accurate preclinical
model for in-stent restenosis, 1310
Thrombolysis should be regarded as first-line
therapy for prosthetic valve thrombosis in the
absence of contraindications, 325
Transplantation in fibrin sealant, 1734
Vascular complications and arteriotomy closure
devices during percutaneous coronary
procedures, 2095
World Trade Center attack and cardiac events: fact
or fear?, 1732
Leukocytes
Elevation of endothelial microparticles, platelets,
and leukocyte activation in patients with
venous thromboembolism, 1467
Platelet P-selectin plays an important role in
arterial thrombogenesis by forming large
stable platelet-leukocyte aggregates, 1280
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